105 related articles for article (PubMed ID: 23726027)
1. Synthesis and biological evaluation of a novel (99m)Tc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia.
Joyard Y; Le Joncour V; Castel H; Diouf CB; Bischoff L; Papamicaël C; Levacher V; Vera P; Bohn P
Bioorg Med Chem Lett; 2013 Jul; 23(13):3704-8. PubMed ID: 23726027
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker.
Chu T; Li R; Hu S; Liu X; Wang X
Nucl Med Biol; 2004 Feb; 31(2):199-203. PubMed ID: 15013485
[TBL] [Abstract][Full Text] [Related]
3. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
[TBL] [Abstract][Full Text] [Related]
4. On the structural modification of 2-nitroimidazole-(99m)Tc(CO)(3) complex, a hypoxia marker, for improving in vivo pharmacokinetics.
Mallia MB; Kumar C; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2012 Nov; 39(8):1236-42. PubMed ID: 22938843
[TBL] [Abstract][Full Text] [Related]
5. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
Mallia MB; Mittal S; Sarma HD; Banerjee S
Bioorg Med Chem Lett; 2016 Jan; 26(1):46-50. PubMed ID: 26615889
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging.
Lu X; Zhao L; Xue T; Zhang H
J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042
[TBL] [Abstract][Full Text] [Related]
7. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of a novel (99m)Tc-labeled bioreductive probe for tumor hypoxia imaging.
Kimura S; Umeda IO; Moriyama N; Fujii H
Bioorg Med Chem Lett; 2011 Dec; 21(24):7359-62. PubMed ID: 22078213
[TBL] [Abstract][Full Text] [Related]
9. In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting.
Sun W; Chu T
Bioorg Med Chem Lett; 2015 Oct; 25(20):4453-6. PubMed ID: 26358160
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
11. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Venkatesh M; Banerjee S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5233-7. PubMed ID: 18774708
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
[TBL] [Abstract][Full Text] [Related]
13. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.
Wolfe HR; Mendizabal M; Lleong E; Cuthbertson A; Desai V; Pullan S; Fujii DK; Morrison M; Pither R; Waldman SA
J Nucl Med; 2002 Mar; 43(3):392-9. PubMed ID: 11884500
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
16. Development of (99m)Tc-N4-NIM for molecular imaging of tumor hypoxia.
Ali MS; Kong FL; Rollo A; Mendez R; Kohanim S; Smith DL; Yang DJ
J Biomed Biotechnol; 2012; 2012():828139. PubMed ID: 22719210
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers.
Zhang Y; Chu T; Gao X; Liu X; Yang Z; Guo Z; Wang X
Bioorg Med Chem Lett; 2006 Apr; 16(7):1831-3. PubMed ID: 16460938
[TBL] [Abstract][Full Text] [Related]
19. Purification-Free Method for Preparing Technetium-99m-Labeled Multivalent Probes for Enhanced in Vivo Imaging of Saturable Systems.
Mizuno Y; Uehara T; Hanaoka H; Endo Y; Jen CW; Arano Y
J Med Chem; 2016 Apr; 59(7):3331-9. PubMed ID: 26999587
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
